Lee:Literature Proteasomes
From OpenWetWare
(Difference between revisions)
(→resistance mechanisms for proteasome inhibitors) |
|||
| Line 31: | Line 31: | ||
==LMP2/7== | ==LMP2/7== | ||
| - | + | # pmid=9419215 | |
| - | # | + | # pmid=12456675 (C-terminal Myc and FLAG tags for MECL, LMP2,Delta, Z) |
| - | # | + | # pmid=10329130 (modification of prepeptide sequence) |
| - | # | + | # pmid=10363659 |
| - | # | + | # pmid=9321388 (GFP fusion) |
| - | # | + | # pmid=18728217 |
| - | # | + | # pmid=19525961 |
| - | # | + | |
| - | + | ||
==Resistance mechanisms for proteasome inhibitors== | ==Resistance mechanisms for proteasome inhibitors== | ||
| Line 45: | Line 44: | ||
# Lü S, Yang J, Song X, Gong S, Zhou H, Guo L, Song N, Bao X, Chen P, Wang J. Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line. J Pharmacol Exp Ther. 2008 Aug;326(2):[http://jpet.aspetjournals.org/content/326/2/423.full.pdf+html 423-31]. (pmid=18502982) | # Lü S, Yang J, Song X, Gong S, Zhou H, Guo L, Song N, Bao X, Chen P, Wang J. Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line. J Pharmacol Exp Ther. 2008 Aug;326(2):[http://jpet.aspetjournals.org/content/326/2/423.full.pdf+html 423-31]. (pmid=18502982) | ||
# Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem. 2008 Jan 1;103(1):[http://onlinelibrary.wiley.com/doi/10.1002/jcb.21405/pdf 270-83]. (pmid=17516511) | # Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem. 2008 Jan 1;103(1):[http://onlinelibrary.wiley.com/doi/10.1002/jcb.21405/pdf 270-83]. (pmid=17516511) | ||
| + | |||
| + | ==Proteasome inhibitors in lung cancer== | ||
| + | |||
| + | |||
| + | ==Proteasome inhibitors in pancreatic cancer== | ||
| + | |||
==NF-kB== | ==NF-kB== | ||
| - | |||
#1 pmid=16889756 | #1 pmid=16889756 | ||
#2 pmid=16724054 | #2 pmid=16724054 | ||
#3 pmid=17183360 | #3 pmid=17183360 | ||
#4 pmid=16618413 | #4 pmid=16618413 | ||
| - | |||
==MDR1 & apoptosis, NF-kB== | ==MDR1 & apoptosis, NF-kB== | ||
Revision as of 12:10, 19 January 2011
Home Research Lab Members Publications JC Transporters PK/PD/PGx Proteasomes Links Internal Contact
|
Feel free to add articles ...
Proteasome Biology general review
Immunoproteasome
LMP2/7
Resistance mechanisms for proteasome inhibitors
Proteasome inhibitors in lung cancerProteasome inhibitors in pancreatic cancerNF-kB
MDR1 & apoptosis, NF-kB
|


